华润江中药业股份有限公司第十届董事会第十二次会议决议公告

Core Viewpoint - The company approved the grant of reserved restricted stocks to 28 eligible participants under its second restricted stock incentive plan, with a total of 660,000 shares at a price of 13.70 yuan per share on February 3, 2026 [2][9][25]. Group 1: Meeting Details - The 12th meeting of the 10th Board of Directors was held on February 3, 2026, with all 11 directors present, complying with the relevant regulations [1][2]. - The meeting was chaired by Chairman Liu Weiquan, and the agenda included the approval of the restricted stock incentive plan [2]. Group 2: Restricted Stock Incentive Plan - The company approved the grant of 660,000 reserved restricted stocks to 28 eligible participants, with the grant date set for February 3, 2026, and the grant price at 13.70 yuan per share [2][9][25]. - The decision followed the completion of necessary procedures and disclosures, including prior approvals from the Compensation and Assessment Committee [3][4][5]. Group 3: Compliance and Conditions - The Board confirmed that all conditions for granting the restricted stocks were met, including compliance with legal and regulatory requirements [12][18]. - The performance assessment criteria for the company and individual participants were established, ensuring that the incentive plan aligns with the company's strategic goals [15][16]. Group 4: Financial Impact - The company will determine the fair value of the restricted stocks based on the closing price on the grant date, which will affect the accounting costs associated with the incentive plan [25].